Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27955,108,1.30 [0.88-1.91],0.190560256785773
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28540,146,1.45 [1.04-2.01],0.0275878432916863
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",28285,1026,1.17 [1.02-1.33],0.0203436245152987
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Candidiasis,28573,309,1.16 [0.91-1.47],0.2369366653503656
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27771,2818,1.17 [1.08-1.27],0.0001154231077834
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),28022,2120,1.34 [1.23-1.46],6.844561292692962e-11
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,28357,1019,1.13 [0.98-1.29],0.0841403207866769
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,28485,43,1.93 [1.14-3.25],0.0136029898095957
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,27286,657,1.27 [1.08-1.49],0.0036697356874796
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,26379,632,1.48 [1.27-1.73],4.038047363126335e-07
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26628,174,1.43 [1.06-1.93],0.0197084528834334
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,21287,1232,1.22 [1.09-1.37],0.0007705279827163
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26383,288,1.21 [0.95-1.56],0.1248266571840787
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,28524,1186,1.13 [1.00-1.28],0.048839877426649
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,28635,371,1.12 [0.90-1.40],0.3242090640951502
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27882,623,1.23 [1.04-1.46],0.0141449649776337
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28573,726,1.24 [1.07-1.45],0.0053780800712578
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27486,148,1.44 [1.04-2.00],0.0295634562714274
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28677,33,1.18 [0.57-2.44],0.6594518840433448
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,28482,635,1.24 [1.05-1.46],0.0093930015896972
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28516,74,1.45 [0.91-2.32],0.1172675706650899
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28579,175,1.23 [0.90-1.70],0.195984268556099
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28564,160,1.23 [0.88-1.72],0.2205365346879829
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27603,344,1.11 [0.88-1.40],0.3597356430778752
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27508,249,1.02 [0.77-1.36],0.864497302973366
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,27420,82,1.26 [0.80-1.99],0.3232108128618253
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28649,54,1.69 [1.00-2.85],0.0516775955869895
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28614,130,1.13 [0.77-1.65],0.5286539935620231
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral warts,28528,44,1.32 [0.71-2.45],0.3727285299839262
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],28535,51,0.69 [0.36-1.35],0.2831865270870997
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,28378,328,0.82 [0.63-1.06],0.1292220965929423
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28583,78,0.64 [0.37-1.11],0.1086225326486769
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28562,83,0.75 [0.44-1.26],0.2733933184051447
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12802,45,0.58 [0.27-1.25],0.165406291743412
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",28479,1216,1.08 [0.96-1.23],0.2022984984815131
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of meninges,28665,51,0.71 [0.37-1.39],0.3216953812221634
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28641,53,0.77 [0.40-1.47],0.4246284351458727
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28655,96,1.08 [0.69-1.68],0.7403872799384117
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of ovary,15811,101,0.78 [0.49-1.24],0.285322436028985
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28670,285,1.18 [0.92-1.52],0.1927246205328179
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Caecum,28667,210,1.11 [0.82-1.50],0.4983991252125674
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28607,61,1.09 [0.62-1.90],0.7650471230500655
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Descending colon,28669,182,1.19 [0.87-1.62],0.2766080114673545
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,28631,301,1.06 [0.83-1.37],0.6406533003069415
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28602,558,1.14 [0.95-1.37],0.1607519653658712
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28671,323,1.16 [0.91-1.47],0.2265307098956185
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Carcinoma in situ of breast,13604,89,1.07 [0.67-1.71],0.7887833968008253
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13652,101,0.89 [0.57-1.41],0.6294380940666235
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24785,31,1.54 [0.77-3.08],0.2201565953353669
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24794,40,1.16 [0.59-2.29],0.6595985602543271
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28633,113,1.17 [0.78-1.75],0.4438428712500183
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma, any site",28633,111,1.20 [0.80-1.80],0.3733553729215342
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Leiomyoma of uterus,15157,428,0.90 [0.72-1.12],0.3421117794168343
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Lung cancer and mesothelioma,21303,181,1.11 [0.80-1.55],0.5319220681821486
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Lymphoid leukaemia,24783,29,1.31 [0.61-2.80],0.488711164366711
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24906,152,1.45 [1.05-2.00],0.0232184139780656
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24840,86,1.06 [0.66-1.69],0.8058738229712942
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13708,85,1.39 [0.91-2.12],0.1331414873649435
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24807,53,2.89 [1.99-4.20],2.5418346070886054e-08
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24823,69,1.25 [0.76-2.03],0.376681091094779
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24827,73,1.26 [0.79-2.01],0.3237188527464437
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13680,57,0.76 [0.40-1.41],0.3767391762979835
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24813,59,0.71 [0.38-1.33],0.2841767643615146
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11557,426,0.95 [0.76-1.19],0.6472923262030027
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24847,93,1.33 [0.87-2.02],0.1895052600264407
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24811,57,0.89 [0.49-1.62],0.7107253762580581
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24821,67,0.43 [0.23-0.80],0.0070624353610739
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi,28429,220,1.12 [0.84-1.51],0.4457108148141849
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi of trunk,28625,98,1.35 [0.89-2.05],0.16223714504439
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanoma in situ,24769,52,0.63 [0.32-1.24],0.1852089438559222
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24816,62,0.90 [0.51-1.61],0.7316747923352072
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24879,125,0.91 [0.60-1.37],0.6504041682754591
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24876,122,1.15 [0.79-1.67],0.4570433579127014
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24825,71,0.74 [0.43-1.30],0.301940226074867
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Other benign neoplasms of skin,28487,143,0.83 [0.56-1.23],0.3591267108094605
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",25421,667,1.02 [0.86-1.21],0.8135306963148757
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",25454,700,1.05 [0.89-1.24],0.5479723885689378
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28397,293,1.22 [0.95-1.56],0.1146724778389617
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,27205,56,1.50 [0.90-2.50],0.1237328107709762
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,28176,72,2.19 [1.49-3.20],5.84047280835921e-05
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27848,2301,1.25 [1.15-1.37],5.988108340399558e-07
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,27449,25,2.20 [1.19-4.04],0.0113365684369563
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,28314,37,1.20 [0.59-2.46],0.6086987434577795
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,28217,1068,1.28 [1.13-1.46],0.0001230951620834
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,28217,1068,1.28 [1.13-1.46],0.0001230951620834
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,27209,60,2.06 [1.33-3.18],0.0011414634360342
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,28383,959,1.27 [1.11-1.46],0.0003944598872564
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,28390,113,1.22 [0.82-1.81],0.3322373680241703
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,28158,54,1.70 [1.04-2.78],0.033930714308183
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,28147,43,1.24 [0.66-2.35],0.5077598381621619
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,28476,199,1.84 [1.43-2.37],2.081270080289596e-06
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28594,71,0.79 [0.46-1.38],0.4165609050507624
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",28443,166,1.88 [1.43-2.46],5.166787230244834e-06
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,27501,77,0.79 [0.46-1.33],0.3709609007685236
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24645,221,1.94 [1.55-2.44],1.2767460875406804e-08
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26686,131,1.31 [0.91-1.88],0.1497459976860553
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26699,144,2.37 [1.80-3.11],5.291100744993397e-10
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24463,39,1.83 [1.02-3.28],0.0413639653978772
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26619,72,1.29 [0.80-2.08],0.3017441146416458
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,26268,156,0.95 [0.66-1.37],0.7867409025430321
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",28528,174,1.49 [1.11-1.99],0.0074448309053344
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,28402,48,1.43 [0.80-2.53],0.2242726139181339
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,28392,38,1.01 [0.49-2.09],0.9735606393449898
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,28248,1701,0.93 [0.84-1.04],0.2272945400851966
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25687,1651,0.95 [0.85-1.06],0.3585864934003931
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24466,42,1.27 [0.67-2.43],0.4623110036539801
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26935,59,1.74 [1.08-2.79],0.0225645018298785
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24619,195,1.07 [0.78-1.47],0.6878349916713442
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24490,66,1.38 [0.84-2.27],0.2089855316300099
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26900,2476,1.06 [0.97-1.16],0.1692567744162855
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24547,123,1.57 [1.11-2.23],0.0112402164635385
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24826,402,1.21 [0.98-1.50],0.0771002108152129
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28573,283,1.02 [0.78-1.33],0.8925901339695999
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,28405,115,0.72 [0.46-1.12],0.1487861689801906
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24525,101,1.15 [0.75-1.77],0.5232968139949787
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24464,40,1.58 [0.86-2.92],0.1420601340367353
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,28232,1356,0.96 [0.85-1.08],0.4809000623671307
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24555,131,1.72 [1.26-2.37],0.0007510724378599
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24595,171,1.81 [1.37-2.37],2.169374715345867e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24830,406,1.21 [0.98-1.49],0.0832758360961593
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24486,62,1.65 [1.02-2.66],0.0406835532422837
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,28398,108,0.75 [0.48-1.19],0.2204191043564919
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24731,307,1.79 [1.45-2.21],4.70314288438287e-08
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24730,306,1.19 [0.94-1.53],0.1549557889147516
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,26173,61,1.39 [0.82-2.36],0.2281923174676312
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27961,3537,1.15 [1.07-1.24],0.0001805511971765
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26914,38,1.73 [0.93-3.22],0.0856662655077062
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26938,62,1.19 [0.69-2.07],0.5296682760103084
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,28486,2003,0.94 [0.85-1.04],0.224958520523807
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",28491,2001,0.94 [0.85-1.04],0.2051875769141142
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26914,38,0.79 [0.37-1.71],0.5569842289291782
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,28343,1285,0.91 [0.80-1.04],0.155957908715442
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",25349,925,1.53 [1.35-1.74],6.354239744753921e-11
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28667,139,2.23 [1.70-2.92],5.0308922971146965e-09
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,28389,35,0.95 [0.44-2.06],0.905823307187837
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,27147,89,1.05 [0.66-1.67],0.843271663952406
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,27176,118,0.94 [0.62-1.43],0.7768233751905858
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",24561,137,1.20 [0.83-1.73],0.3380114707727909
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26814,124,2.04 [1.50-2.77],5.571620032831868e-06
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1775,73,2.01 [1.43-2.81],5.472997510287143e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1882,195,1.38 [1.05-1.82],0.0226732338287728
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26732,42,2.28 [1.42-3.64],0.0006078364952768
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1740,38,1.66 [0.93-2.96],0.0871520486205087
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,28241,1551,1.53 [1.39-1.68],4.953540324946575e-18
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,28425,71,1.17 [0.71-1.92],0.5486755869907616
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,26394,282,1.31 [1.02-1.69],0.0353833252915812
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24847,423,1.61 [1.33-1.94],6.381746939156735e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28586,183,1.03 [0.75-1.43],0.8414729657986809
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27919,57,0.78 [0.42-1.46],0.4368799974756636
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,27355,818,1.07 [0.92-1.25],0.3540730203167704
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27967,105,0.93 [0.59-1.45],0.745709144907089
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27893,31,2.10 [1.16-3.81],0.0145766331179457
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27970,108,1.50 [1.04-2.17],0.0308992696047021
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20460,977,1.38 [1.22-1.57],4.347903886239155e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,AV-block,26103,192,1.48 [1.12-1.95],0.0055497278990074
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28643,270,1.21 [0.94-1.56],0.1460172108196566
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiac arrest,19601,118,1.90 [1.39-2.60],5.93731322666765e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,26049,138,1.22 [0.85-1.74],0.2849727162947267
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25994,83,1.33 [0.85-2.08],0.2103770886965948
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28679,21,0.47 [0.16-1.36],0.1637948284958479
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,26463,552,1.53 [1.30-1.80],2.835221178112064e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27934,1408,1.06 [0.95-1.19],0.3077159632736955
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26666,6254,1.07 [1.01-1.13],0.0142530077345251
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27472,191,1.07 [0.78-1.48],0.6570607042967416
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Endocarditis,25957,46,1.30 [0.72-2.36],0.388100763880837
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28558,533,1.57 [1.34-1.83],2.7735757566501842e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertension,27265,5089,1.05 [0.99-1.12],0.1148849325177531
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",27282,5106,1.05 [0.99-1.12],0.1025530454956873
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",28505,60,5.03 [3.93-6.44],1.101544254277325e-37
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22265,89,2.41 [1.75-3.32],6.630105195690624e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,22240,64,1.44 [0.89-2.34],0.1358215086845795
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypotension,28571,716,1.28 [1.10-1.49],0.0016614053891112
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,28129,64,1.02 [0.59-1.76],0.9545313453484288
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",28099,1562,1.05 [0.94-1.17],0.4242187541597247
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28440,317,0.93 [0.72-1.20],0.5827949062316787
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,26111,200,1.67 [1.30-2.16],7.704885340520723e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28412,619,1.15 [0.97-1.36],0.1115626097657248
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",27042,505,1.16 [0.96-1.40],0.1243364418083588
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28619,123,0.84 [0.55-1.27],0.4066430274247492
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28662,211,1.33 [1.01-1.76],0.0406613699879991
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Oesophageal varices,27322,41,2.53 [1.89-3.39],4.80823389897384e-10
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other aneurysm,27914,52,1.41 [0.81-2.48],0.2282898839523027
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,26161,250,1.25 [0.96-1.62],0.0959637862882309
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27928,66,1.22 [0.73-2.04],0.4426237630748332
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,28009,147,1.50 [1.09-2.06],0.0133502347390808
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,26043,132,1.36 [0.95-1.93],0.0899140611868334
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other disorders of veins,27357,76,1.90 [1.28-2.84],0.0015370638280208
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,27331,50,1.71 [1.01-2.90],0.0464996432873323
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27872,39,1.36 [0.72-2.59],0.347407458483294
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,27375,94,1.21 [0.79-1.87],0.3846594036583891
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26519,608,1.47 [1.26-1.72],1.0506660175324663e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27903,48,3.68 [2.66-5.09],3.762677172131279e-15
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,28215,353,1.00 [0.79-1.27],0.9757616536338548
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,28216,161,2.03 [1.57-2.61],4.412869312589143e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",28079,246,1.14 [0.87-1.49],0.3518530749499814
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19743,260,1.53 [1.21-1.94],0.0004530605694082
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,28049,214,1.30 [0.98-1.71],0.064023330448711
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27545,264,1.10 [0.84-1.44],0.4708749644158562
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28406,351,1.02 [0.80-1.29],0.8872288292075488
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28638,343,1.57 [1.29-1.92],9.026368295770908e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,26094,183,1.64 [1.25-2.16],0.0004225325281984
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,28212,157,1.97 [1.52-2.55],2.857355141481173e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27953,120,0.92 [0.61-1.38],0.6805742195155182
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28433,368,0.95 [0.75-1.19],0.6374287719483563
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28406,405,1.01 [0.81-1.25],0.9564493678425168
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,28104,56,1.13 [0.64-2.00],0.6776993586665607
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27917,56,1.14 [0.64-2.04],0.649840941380552
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,28271,148,1.04 [0.73-1.50],0.8108824399510288
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27978,185,1.03 [0.75-1.42],0.8446682311165408
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Varicose veins,27613,332,1.47 [1.18-1.82],0.0004487440872956
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27871,48,1.65 [0.97-2.81],0.0635643588748611
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28498,552,1.03 [0.86-1.25],0.7304008703705773
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28516,388,1.85 [1.55-2.21],1.6846944763228522e-11
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25569,1474,0.92 [0.82-1.04],0.1820315646757965
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Any mental disorder,27896,3801,1.08 [1.01-1.16],0.0321071647422241
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28450,460,1.67 [1.40-1.98],7.648962670136504e-09
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25826,1731,0.97 [0.87-1.08],0.5266193376827617
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",24190,95,1.13 [0.72-1.77],0.6063056748752577
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Smoking dependency,28123,1573,1.22 [1.10-1.36],0.0002196528150559
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25921,1826,1.26 [1.14-1.39],4.047152899933047e-06
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Vascular dementia,28562,21,1.16 [0.48-2.80],0.7462934566765828
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Alzheimer disease,28679,66,1.32 [0.80-2.18],0.28054713613279
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Bell's palsy,26953,78,1.15 [0.71-1.87],0.5665019147258723
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27368,493,0.88 [0.72-1.09],0.2431502149213643
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral cysts,28311,212,1.52 [1.17-1.98],0.0017624530084336
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28593,236,1.00 [0.75-1.32],0.974319190005544
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,28534,24,1.25 [0.53-2.96],0.6050536709531004
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28664,52,1.28 [0.73-2.24],0.3972730462750936
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",28160,61,1.68 [1.04-2.71],0.0323188027733976
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Epilepsy,27046,267,1.06 [0.81-1.38],0.6951609377498924
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,28177,1398,0.92 [0.82-1.04],0.1863297779247443
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28648,280,1.21 [0.94-1.56],0.134075811941464
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,28139,1702,1.15 [1.04-1.28],0.0066700645478842
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Generalized epilepsy,28295,54,1.55 [0.90-2.65],0.1115483570895118
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hemiplegia,28526,169,0.95 [0.67-1.34],0.7668383810576539
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hydrocephalus,28147,48,1.45 [0.82-2.56],0.1999322509567701
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28655,64,0.95 [0.54-1.67],0.8570660645330234
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26958,83,0.73 [0.43-1.22],0.2283775239674572
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26963,88,1.24 [0.79-1.93],0.3501517646326887
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Memory loss,28526,76,0.70 [0.41-1.21],0.1987695324815952
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Migraine,27220,441,0.80 [0.64-1.00],0.0465500030129429
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28585,391,0.81 [0.64-1.02],0.0776142584963221
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Motor neuron disease,20880,99,0.85 [0.53-1.37],0.5010063761311121
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28476,149,0.67 [0.45-0.99],0.0441433536678522
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",28046,1171,0.94 [0.83-1.08],0.3931069771446253
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Neurological diseases,27197,3189,1.00 [0.92-1.08],0.9905327384337278
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28586,76,1.63 [1.07-2.48],0.0219871621712541
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",27275,400,0.92 [0.73-1.15],0.4488756454194191
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28607,243,1.59 [1.25-2.01],0.0001244799300656
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23919,315,1.07 [0.83-1.37],0.6163778716117889
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,28161,62,1.04 [0.59-1.83],0.8881312635673385
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,28218,119,0.65 [0.42-1.01],0.0568849250542442
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,28461,93,1.57 [1.07-2.33],0.0227186071580644
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26971,96,1.10 [0.70-1.71],0.6817924739933002
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other headache syndromes,26842,63,0.77 [0.42-1.41],0.3980483982366178
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,28553,454,1.13 [0.93-1.39],0.2196488882151742
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,27386,607,0.87 [0.72-1.05],0.1436556163583704
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Parkinson's disease,28666,166,1.03 [0.73-1.46],0.8492374744385095
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,28164,65,0.76 [0.43-1.36],0.3608278285904108
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Restless leg syndrome,28678,48,1.25 [0.69-2.28],0.4587362670925404
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,28423,527,0.86 [0.71-1.05],0.1373309604842084
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,28401,37,1.06 [0.52-2.16],0.8701749538334411
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28663,125,0.97 [0.65-1.45],0.8786607911864057
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26908,33,1.08 [0.50-2.34],0.840694530130759
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28679,67,1.33 [0.81-2.19],0.2594459306377304
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28549,20,1.19 [0.49-2.91],0.7006308637517524
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,28184,41,1.00 [0.49-2.00],0.9890096149030646
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,28317,226,1.15 [0.86-1.53],0.3452687836234864
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28588,199,1.79 [1.40-2.30],4.79529895117739e-06
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27911,38,1.01 [0.50-2.06],0.975356957612241
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27950,77,1.03 [0.62-1.71],0.913432093260003
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",28585,31,1.35 [0.65-2.82],0.4268308769310043
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,28471,66,0.97 [0.56-1.71],0.9279107799689048
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1746,44,1.52 [0.87-2.66],0.1403423313348137
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2060,89,1.89 [1.39-2.58],5.774796768005089e-05
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,28221,78,1.04 [0.64-1.71],0.8691269751748051
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28547,640,1.36 [1.16-1.59],0.0001593156825228
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",28365,492,0.97 [0.79-1.18],0.7395240709613358
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,28013,140,0.92 [0.62-1.36],0.6741975479042952
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28584,493,1.27 [1.05-1.53],0.0128562923116142
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28666,54,0.86 [0.45-1.61],0.6282108384543024
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,28509,418,1.25 [1.02-1.54],0.0320315507207905
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28635,230,1.17 [0.88-1.55],0.2722840740603043
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,28613,132,1.12 [0.76-1.64],0.5778429383870911
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27890,17,0.80 [0.26-2.49],0.7048718493800084
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27902,29,0.32 [0.12-0.83],0.0194278194636793
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27905,32,0.80 [0.35-1.86],0.6073548097416919
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28629,395,1.15 [0.92-1.42],0.2116693026325719
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,28337,103,0.95 [0.61-1.49],0.8329717958247113
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,28118,27,1.81 [0.90-3.61],0.0949210758399274
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,28482,77,1.37 [0.87-2.17],0.1783988014966779
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,28559,154,1.10 [0.77-1.57],0.603016993243923
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,28256,165,1.26 [0.91-1.75],0.1646533289924073
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,28558,77,0.88 [0.52-1.50],0.6481528769775986
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28494,260,1.06 [0.81-1.39],0.660546550046065
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,28265,122,0.84 [0.55-1.28],0.4171271349628288
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27944,1092,1.03 [0.90-1.18],0.6767518285094092
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,28532,127,1.17 [0.80-1.71],0.4318846475542207
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28652,115,1.47 [1.02-2.12],0.0385333113764728
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,28145,272,0.94 [0.71-1.23],0.6333268198138448
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,28444,39,1.59 [0.87-2.91],0.1333316708190563
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28649,37,0.89 [0.41-1.90],0.7561282608581811
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27914,41,1.55 [0.84-2.86],0.1617263578037475
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27994,121,0.99 [0.67-1.49],0.9796254536113718
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27979,72,1.15 [0.69-1.90],0.5914422009152078
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,28151,60,1.43 [0.86-2.39],0.1700912317586467
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27959,52,1.25 [0.70-2.24],0.4527076677878053
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,28293,59,1.03 [0.58-1.84],0.9166724826434544
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",28329,95,1.50 [1.01-2.23],0.044512079081252
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27966,93,0.86 [0.53-1.40],0.5417774072899875
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,28034,127,0.99 [0.66-1.48],0.9555345803928538
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27944,37,0.89 [0.42-1.89],0.7665045145230758
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27707,855,1.13 [0.98-1.31],0.0983412373255593
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27922,49,0.93 [0.48-1.80],0.8249205451475068
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28458,315,0.90 [0.70-1.17],0.4263440293437585
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,28182,39,1.18 [0.59-2.37],0.6309941873185363
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),28273,130,1.51 [1.08-2.10],0.0161674532168498
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,28477,63,1.20 [0.70-2.09],0.506328780597739
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28636,100,0.89 [0.56-1.40],0.6041337392308186
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,28553,140,1.16 [0.81-1.66],0.419109708310788
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,28469,55,1.13 [0.63-2.03],0.6890343115776375
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,28470,56,0.73 [0.39-1.37],0.3227848359811219
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28589,552,0.91 [0.75-1.10],0.3201943732110947
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,28380,343,1.01 [0.79-1.28],0.9512373337104116
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,28137,100,0.92 [0.58-1.45],0.7105376958639433
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,28120,83,1.17 [0.73-1.86],0.5127367967809129
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute pharyngitis,28383,84,0.74 [0.44-1.24],0.2518210059075771
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28538,239,0.93 [0.69-1.25],0.640615134233241
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,28362,63,0.97 [0.55-1.71],0.9062757195613944
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,All influenza,27319,80,1.23 [0.78-1.95],0.3780419579809941
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),27317,78,1.18 [0.73-1.90],0.4925876174627754
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),21255,133,1.35 [0.94-1.94],0.1006416442233109
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Allergic rhinitis,28521,321,0.81 [0.62-1.05],0.1069636602151708
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22807,1833,1.08 [0.97-1.20],0.1566015757581106
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22924,1802,1.06 [0.95-1.17],0.3035715310868354
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),28382,99,1.30 [0.87-1.97],0.2032768131213104
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",27298,59,0.98 [0.55-1.75],0.949926619806042
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Bronchiectasis,25523,191,1.04 [0.75-1.43],0.8261227983901999
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",25376,44,0.54 [0.26-1.14],0.1042503200939146
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27782,2450,1.09 [1.00-1.19],0.0457065295742174
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",27149,69,0.96 [0.56-1.66],0.8876529680929882
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,27255,175,1.44 [1.07-1.94],0.0172045131491131
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28570,747,1.19 [1.02-1.38],0.0270347441682143
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,27215,135,0.76 [0.51-1.15],0.1967004611854044
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26690,4426,1.10 [1.03-1.17],0.0060619664548903
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27473,393,0.93 [0.74-1.17],0.5428901085109702
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Early onset COPD,28348,525,1.24 [1.03-1.47],0.0193311441496911
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Emphysema,25524,192,1.18 [0.87-1.60],0.2958526545996864
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27386,119,1.18 [0.80-1.73],0.4070918973093761
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,28491,1252,1.29 [1.15-1.45],1.0411020480625314e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,27412,145,1.27 [0.90-1.79],0.1696439388140076
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Later onset COPD,27192,222,1.08 [0.81-1.44],0.6071581254949627
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28670,161,1.48 [1.10-2.00],0.0105641902423644
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Nasal polyp,27197,117,1.54 [1.09-2.20],0.0156225397930321
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28462,641,1.33 [1.13-1.55],0.0005188807001882
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,28497,1296,1.30 [1.16-1.46],3.872246298234509e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27998,918,0.98 [0.84-1.14],0.7869641116456625
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other pleural conditions,27236,35,0.81 [0.37-1.79],0.6049591721643129
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28623,208,1.53 [1.17-1.99],0.0017154777598312
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28594,881,1.22 [1.06-1.40],0.0052273771116151
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural effusion,27821,620,1.57 [1.35-1.82],4.6303055829152484e-09
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural plaque,27258,57,1.36 [0.82-2.27],0.2309719929233629
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",28274,1035,1.31 [1.15-1.48],2.407068302572735e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28649,140,1.64 [1.20-2.23],0.0016767943154144
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pneumothorax,27266,65,1.38 [0.85-2.26],0.1941316653959649
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pollen allergy,28642,274,0.78 [0.58-1.03],0.0817995205214544
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pulmonary oedema,28454,39,2.53 [1.58-4.03],0.0001001505814055
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,21160,38,1.56 [0.84-2.91],0.1581176298144289
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28442,621,1.32 [1.13-1.56],0.0006837922453572
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,27401,321,0.81 [0.62-1.05],0.1080751826512392
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Viral pneumonia,27437,198,0.88 [0.64-1.22],0.446380056417395
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",28402,170,0.83 [0.58-1.18],0.2902448777406163
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16560,105,1.12 [0.72-1.73],0.6136536839634665
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21959,66,0.96 [0.55-1.67],0.8827391346499099
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,28471,163,0.77 [0.53-1.12],0.1718832651061029
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute gastritis,22926,75,1.23 [0.75-2.00],0.4131939264093717
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,27025,171,1.25 [0.91-1.71],0.1623427053321305
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute peritonitis,28227,76,2.16 [1.49-3.14],5.181796983000089e-05
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27871,86,4.17 [3.28-5.30],1.5104910833005958e-31
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Barrett oesophagus,23215,364,0.96 [0.76-1.22],0.7367897412296579
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26911,57,1.36 [0.80-2.32],0.258731776630235
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",28256,57,1.36 [0.80-2.32],0.2521419531534752
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholecystitis,27041,187,0.63 [0.44-0.90],0.0102260554440215
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,27793,939,0.75 [0.64-0.87],0.0001765025964504
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,23116,265,1.15 [0.88-1.50],0.3000152168481765
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26899,45,1.97 [1.16-3.33],0.0116419134578955
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",28526,81,4.24 [3.37-5.33],6.890914659698109e-35
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Coeliac disease,27203,120,0.57 [0.37-0.90],0.0156681705453361
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Collagenous colitis,27062,62,1.14 [0.65-1.98],0.6457967161826489
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28488,215,0.96 [0.70-1.30],0.7878647270643644
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Constipation,28449,1219,1.22 [1.08-1.38],0.0012944872823499
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn disease,27098,98,1.03 [0.66-1.61],0.8943462753688766
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",28320,69,1.07 [0.63-1.80],0.8062299509131108
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,27095,95,1.41 [0.94-2.13],0.0990101325143594
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Dental caries,27809,271,1.05 [0.81-1.38],0.699992101937508
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26524,1892,0.84 [0.75-0.93],0.0012698072336856
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,28515,207,0.65 [0.46-0.90],0.0106920841939852
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of liver,28556,771,1.74 [1.52-1.98],9.907101165462132e-17
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26909,4058,1.00 [0.93-1.07],0.9087237409990746
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",28177,639,1.15 [0.97-1.36],0.1186409812838896
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28596,445,1.10 [0.90-1.35],0.3689286240892049
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27675,137,0.95 [0.65-1.40],0.8030707078817858
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,27505,72,1.13 [0.67-1.89],0.6465331073013026
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,28391,1308,1.00 [0.88-1.13],0.9705856612382208
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of tongue,27518,126,1.10 [0.74-1.62],0.6392119026062645
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",28141,1287,0.86 [0.76-0.98],0.0247694367516693
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,24427,2534,0.88 [0.80-0.96],0.0061937442172319
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,23000,149,1.46 [1.05-2.01],0.0231731354734514
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28606,118,1.39 [0.96-2.00],0.0787622272335324
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28537,85,0.57 [0.34-0.97],0.037986734691908
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27889,104,3.75 [3.00-4.67],9.367494866589796e-32
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,22080,187,0.93 [0.67-1.30],0.679854253006059
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,23385,534,0.80 [0.65-0.98],0.0345884027530799
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,23143,292,0.96 [0.74-1.25],0.7588202217535407
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,25190,2339,0.81 [0.73-0.89],1.4761618316719258e-05
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,23274,423,1.07 [0.87-1.33],0.5054888859023143
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23433,8403,0.97 [0.92-1.02],0.1926362346300938
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,GI-bleeding,28138,1055,1.01 [0.88-1.15],0.9257964107180152
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27601,63,1.05 [0.60-1.83],0.8601101002450818
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22854,1342,0.93 [0.82-1.05],0.2427569356115088
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27843,58,3.42 [2.47-4.74],1.3031274728908182e-13
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Hernia,27477,2845,0.89 [0.81-0.97],0.0060111803249942
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impacted teeth,28547,79,0.55 [0.32-0.95],0.031112456469261
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impaction of intestines,21927,34,1.00 [0.46-2.14],0.9899736843735456
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,25336,704,0.98 [0.82-1.16],0.7891001416332726
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",24714,82,1.50 [0.98-2.30],0.0618766165526414
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21970,77,1.28 [0.80-2.06],0.3056487332878754
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,27223,140,0.59 [0.39-0.89],0.0115858171084651
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22486,593,0.85 [0.70-1.03],0.0936408930396078
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28653,404,1.40 [1.15-1.69],0.0006767472789227
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27728,728,1.04 [0.88-1.23],0.630591448689572
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27920,920,0.99 [0.85-1.15],0.8824252037566032
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,23009,158,0.78 [0.53-1.13],0.1915319402893273
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophagitis,23356,505,1.08 [0.89-1.31],0.445583571228729
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28634,140,0.73 [0.49-1.10],0.1340690061494918
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,24683,51,0.83 [0.44-1.59],0.5811840091536186
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,23243,1350,0.99 [0.87-1.11],0.8196932931105061
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,27057,203,0.93 [0.68-1.28],0.6524215667408222
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,27023,169,0.69 [0.48-1.00],0.0493408533701948
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,23448,1555,1.03 [0.92-1.15],0.5853966038608417
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,26975,5082,0.97 [0.91-1.03],0.2848191050949948
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27512,207,0.79 [0.57-1.09],0.1519634042158772
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,28409,624,1.73 [1.50-2.00],6.940169168685222e-14
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,23412,561,1.05 [0.87-1.27],0.5963570374940075
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26942,88,1.05 [0.66-1.69],0.8354677344557824
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28537,386,0.98 [0.78-1.23],0.8767219937839208
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23660,809,1.02 [0.87-1.19],0.8315364705985108
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,28152,1069,1.00 [0.87-1.15],0.9989144612766908
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27734,196,1.25 [0.92-1.69],0.1487730250794389
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,23160,1267,1.19 [1.06-1.34],0.0043583143176669
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24709,1858,1.10 [0.99-1.22],0.0699182582464839
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27870,85,2.59 [1.88-3.56],5.957070341413413e-09
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27805,805,1.02 [0.87-1.19],0.8100560829036981
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",22132,239,1.15 [0.87-1.52],0.3123839531431061
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28521,100,0.66 [0.41-1.07],0.0933915679854679
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,22253,360,1.12 [0.89-1.40],0.3397137459399577
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",27224,141,1.45 [1.04-2.02],0.0286471444398427
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28669,61,0.76 [0.42-1.40],0.3818742620055149
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27556,134,0.90 [0.61-1.34],0.6107444058033726
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Toxic colitis,27033,33,0.58 [0.25-1.36],0.2067384521238454
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,23042,191,0.97 [0.70-1.34],0.852246948443609
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,27152,152,0.79 [0.54-1.16],0.2219048571735942
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",27132,132,0.75 [0.50-1.14],0.1818433893587628
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,24921,289,1.08 [0.84-1.39],0.5267738194882525
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21997,104,1.25 [0.84-1.87],0.277346046372939
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ventral hernia,24866,234,1.02 [0.76-1.36],0.898960747448582
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Volvulus,21959,66,0.89 [0.50-1.56],0.6736905408915517
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,28621,167,1.06 [0.75-1.49],0.7503020776525826
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,28394,81,1.22 [0.78-1.93],0.3867201540936221
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,27142,153,0.72 [0.49-1.06],0.0940604521678711
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,28033,576,1.29 [1.09-1.52],0.0033189912673772
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27663,206,1.03 [0.75-1.40],0.8657654764286569
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,27169,180,1.16 [0.85-1.58],0.3529124179409112
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,28408,238,1.21 [0.92-1.59],0.1780611319099734
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28577,407,1.30 [1.06-1.60],0.0103239102428095
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,28218,48,1.70 [1.01-2.87],0.0443574930318277
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,27160,2686,1.11 [1.02-1.20],0.0178021155284118
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,28203,458,0.96 [0.78-1.19],0.7059731645313876
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,28071,326,0.98 [0.76-1.25],0.855388813057713
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,28278,821,1.23 [1.06-1.42],0.0052573302861519
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28665,49,0.82 [0.42-1.62],0.5743156619947585
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,27046,57,0.32 [0.17-0.60],0.0004517744404059
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27787,42,0.53 [0.25-1.12],0.0959052989076559
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,28402,232,1.26 [0.95-1.66],0.1030252684508579
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,27291,302,1.29 [1.01-1.63],0.0406389782149403
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,27027,38,0.82 [0.38-1.77],0.6193579714510495
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,28593,71,1.20 [0.73-1.97],0.4660121712650245
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27599,142,1.26 [0.89-1.78],0.1846092864702848
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28476,163,0.92 [0.65-1.30],0.636614920675736
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,28203,33,0.95 [0.45-2.02],0.8907119153983393
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,27044,55,1.23 [0.70-2.17],0.4725142023951089
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,28136,1147,1.13 [1.00-1.29],0.0530703576483532
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",27322,333,1.34 [1.07-1.68],0.0097562198591672
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,27031,42,0.74 [0.35-1.55],0.4297336667214185
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28592,279,0.87 [0.66-1.14],0.3035922629229323
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,28234,64,1.33 [0.79-2.21],0.2820444063993671
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28542,229,0.88 [0.66-1.19],0.4219954717818374
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28645,191,1.10 [0.80-1.51],0.5504669872819024
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,27117,128,0.87 [0.58-1.31],0.4985833929880492
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,27185,196,1.01 [0.73-1.40],0.9491887780223364
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28635,181,1.11 [0.80-1.53],0.5348861199799175
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",27126,137,1.54 [1.13-2.10],0.0057757938297954
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28645,123,1.11 [0.76-1.64],0.5901231327516099
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,25175,140,1.10 [0.77-1.59],0.5981319375969254
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26782,4853,0.91 [0.85-0.97],0.0058751474430398
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,25354,3425,0.88 [0.81-0.95],0.0011734731934887
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,25132,97,0.84 [0.52-1.35],0.4654463271266914
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25738,160,0.89 [0.62-1.29],0.5468648511654888
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25745,167,1.35 [0.98-1.86],0.0650586286587442
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,28442,120,1.08 [0.72-1.61],0.7231491432386832
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25626,48,1.30 [0.71-2.38],0.4027107515947169
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22713,784,0.85 [0.72-1.00],0.0483384737252093
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28619,130,0.80 [0.53-1.20],0.2863528652379331
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25881,303,0.74 [0.57-0.98],0.0351225682884349
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,25089,6505,0.93 [0.88-0.99],0.0195356159802375
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,27260,112,1.20 [0.80-1.79],0.3720838654657401
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,25154,119,0.82 [0.54-1.26],0.3662535700873057
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25667,632,0.91 [0.75-1.09],0.2846082234702094
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27755,2177,0.95 [0.87-1.05],0.3373840365475731
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,25268,233,0.87 [0.65-1.19],0.3897449282173612
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,25328,293,0.70 [0.53-0.92],0.0109940481515657
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,25189,154,1.05 [0.73-1.50],0.8047820465936606
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,28144,38,0.63 [0.28-1.39],0.2522385727804965
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,23297,1368,0.84 [0.74-0.95],0.0058457550615816
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,22344,415,1.27 [1.04-1.54],0.0186209017642738
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28624,405,1.29 [1.06-1.57],0.0112128710047413
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,22003,74,0.65 [0.37-1.13],0.1284166999717916
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),22289,360,0.69 [0.53-0.89],0.0036913179242002
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25379,344,0.81 [0.63-1.05],0.1094684418490628
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22731,802,0.79 [0.67-0.94],0.0063602851999084
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,25608,30,1.16 [0.53-2.55],0.7142447004814029
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,26151,573,0.84 [0.70-1.03],0.0891362422610329
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25871,293,0.93 [0.72-1.22],0.6139622943544414
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22677,748,0.77 [0.65-0.92],0.0032186198618567
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,25124,89,1.14 [0.72-1.80],0.5883793158304986
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",25099,64,1.02 [0.58-1.78],0.9465079349607168
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,27208,60,1.57 [0.97-2.54],0.0651180173248391
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,28333,1185,1.12 [0.98-1.27],0.0872465959403664
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27818,670,1.18 [1.00-1.40],0.0553398262772635
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28567,359,0.81 [0.64-1.04],0.0953806798448853
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23767,1838,0.91 [0.82-1.01],0.0789643487855924
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,22011,82,0.77 [0.45-1.30],0.3216537795818275
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,25117,82,1.06 [0.66-1.73],0.8021430649051734
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21957,28,1.80 [0.96-3.35],0.0652716185951741
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),22044,115,0.92 [0.60-1.41],0.7131323259787606
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27388,240,0.93 [0.70-1.25],0.644639257285459
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,27397,249,0.90 [0.67-1.21],0.5037702066937798
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28637,87,1.04 [0.65-1.66],0.8737212633400671
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",27203,1625,0.94 [0.84-1.05],0.2543141621416818
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,25161,126,0.81 [0.53-1.23],0.3191057193389028
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),22050,121,1.01 [0.68-1.51],0.9526977948246568
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,26237,659,0.93 [0.78-1.12],0.454658090943033
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,24059,2130,0.84 [0.76-0.92],0.0005064504689729
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,28167,61,0.55 [0.29-1.03],0.060657019139058
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28653,77,1.18 [0.74-1.90],0.4866682722127087
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,25121,86,0.93 [0.57-1.52],0.7771539760754289
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",26179,1144,1.02 [0.90-1.17],0.7172179937202267
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,25106,71,0.94 [0.55-1.60],0.8252090975779078
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,23097,1168,0.87 [0.76-1.00],0.0464032674761441
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,27253,105,0.60 [0.37-0.96],0.0322592959425414
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,25105,70,0.72 [0.41-1.28],0.2606144706467191
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,25699,121,0.88 [0.58-1.33],0.5396875633517566
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25455,420,1.25 [1.02-1.52],0.0320870854558055
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,28323,217,0.82 [0.60-1.13],0.2342454468286107
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,26062,484,1.05 [0.86-1.29],0.612428739694562
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28576,339,0.85 [0.66-1.08],0.185725938395242
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28661,39,0.42 [0.19-0.93],0.0319316150265573
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,25251,216,0.84 [0.61-1.15],0.2686911380865573
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,23028,622,0.93 [0.77-1.11],0.4171954089596924
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25556,521,1.02 [0.84-1.24],0.8359377656227764
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],25209,174,0.90 [0.63-1.27],0.5486924783086109
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21966,37,1.03 [0.50-2.14],0.9375999754060754
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23773,1844,0.97 [0.88-1.08],0.5868718678415256
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22398,469,0.82 [0.66-1.01],0.0595354337703842
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,28195,89,1.08 [0.68-1.71],0.7504197419747346
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28602,52,1.34 [0.77-2.32],0.3042057497646734
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",27009,31,1.46 [0.76-2.80],0.2593117030148313
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,22008,79,1.17 [0.73-1.89],0.5066253060788966
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,25672,94,0.73 [0.45-1.20],0.2125427228155277
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22292,363,0.79 [0.62-1.01],0.0623869379998964
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,25313,278,0.90 [0.68-1.19],0.4616181180185108
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25799,221,0.93 [0.68-1.26],0.6244271476344196
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,25688,110,0.89 [0.57-1.39],0.6079177091764063
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,24283,50,0.64 [0.32-1.28],0.2046103901110624
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28664,42,0.38 [0.17-0.81],0.0131193978290175
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25662,627,0.94 [0.78-1.13],0.5077964081807691
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],28196,90,0.51 [0.30-0.85],0.0105942415111685
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27546,2511,0.97 [0.89-1.06],0.5240683300973372
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",25150,115,0.91 [0.60-1.40],0.6767926106778845
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25950,372,1.25 [1.01-1.55],0.0391571816324142
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,27233,195,0.79 [0.56-1.10],0.1619303734551448
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25734,156,0.73 [0.50-1.07],0.1094644303808883
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26681,1103,0.97 [0.85-1.11],0.6939395243962501
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,26311,733,0.89 [0.75-1.05],0.1695080021284787
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],25082,47,1.00 [0.52-1.93],0.992002126084593
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,28257,151,0.52 [0.35-0.77],0.0012068982596035
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,25198,163,1.11 [0.79-1.56],0.5556284335275177
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,25096,61,0.92 [0.51-1.66],0.7868941153506666
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21968,39,0.81 [0.38-1.73],0.5817639923165419
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,28095,892,1.51 [1.33-1.71],1.7062300584763774e-10
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11644,78,0.96 [0.58-1.59],0.8674742106718977
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15476,79,1.31 [0.82-2.09],0.2659724540129344
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28366,337,1.29 [1.03-1.61],0.0254121938539382
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,28091,62,0.68 [0.37-1.26],0.221331627786564
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27924,721,1.46 [1.26-1.68],2.778950785662876e-07
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,28482,33,2.13 [1.21-3.73],0.0084561356057792
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,28496,197,1.08 [0.79-1.47],0.6283543251652861
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,26376,167,0.83 [0.58-1.19],0.3115291808172422
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Dialysis,27265,62,1.33 [0.79-2.25],0.2815915159835874
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12399,1176,1.06 [0.94-1.21],0.3424876006317995
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15606,209,0.94 [0.69-1.29],0.7169644485526159
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,11711,145,0.78 [0.53-1.15],0.2116307147363026
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11966,400,0.70 [0.56-0.89],0.0029040022328882
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,12006,440,0.75 [0.60-0.94],0.0140835339879106
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,24182,4445,1.03 [0.97-1.10],0.3509603627938178
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,28520,71,1.22 [0.74-2.01],0.4404611155768402
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,11313,90,1.22 [0.79-1.90],0.3730483322099027
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,27113,235,1.13 [0.85-1.50],0.4160053856948139
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,12002,779,1.08 [0.93-1.26],0.3277542385636897
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15461,245,1.08 [0.81-1.43],0.6050618019707108
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11329,106,0.90 [0.58-1.40],0.6383526296172355
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,15470,130,0.93 [0.63-1.39],0.7355822781645742
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11872,306,0.63 [0.48-0.82],0.0005921434856583
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,26280,71,1.01 [0.60-1.71],0.963984908124082
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,13027,1461,0.84 [0.74-0.94],0.0035301194371756
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,11272,49,1.03 [0.55-1.96],0.9177252745264182
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11670,104,0.75 [0.47-1.18],0.2077395125246217
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28667,39,1.02 [0.50-2.05],0.9647554639990296
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28674,47,0.74 [0.37-1.48],0.4000484844266949
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27782,1573,1.09 [0.98-1.22],0.1282714499054036
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26699,490,1.04 [0.86-1.28],0.6675250842413945
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15467,70,0.75 [0.43-1.31],0.3095985600662724
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28627,328,1.01 [0.79-1.29],0.9279286716516052
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11380,157,1.29 [0.92-1.80],0.1377340311139625
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11345,122,1.27 [0.88-1.84],0.2077586615166479
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11302,79,0.48 [0.27-0.85],0.0112677218271869
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28641,55,0.59 [0.31-1.13],0.1104656102554136
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,27346,1137,1.10 [0.97-1.25],0.1356809887075285
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15342,126,1.06 [0.71-1.57],0.7875485719803409
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11655,89,0.75 [0.45-1.23],0.2474642262030097
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11801,235,0.84 [0.62-1.13],0.2464929527700439
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11626,60,0.93 [0.51-1.67],0.8014082131196381
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11674,108,0.97 [0.63-1.50],0.9067440727845032
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,27148,270,1.08 [0.82-1.41],0.587623609986031
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,28413,114,0.92 [0.60-1.39],0.6801968502747254
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11755,189,0.99 [0.71-1.37],0.945174529632806
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11650,84,0.42 [0.25-0.71],0.0011743972349269
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,12013,447,0.94 [0.76-1.17],0.5751136585011415
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11635,69,0.67 [0.37-1.19],0.1685710815095082
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11962,396,0.97 [0.77-1.22],0.7864539687230613
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,28499,50,1.71 [1.02-2.87],0.0423236338512269
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11336,113,1.00 [0.66-1.50],0.9841086627315856
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,28468,1590,1.36 [1.23-1.50],2.3448546103773423e-09
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",27026,148,1.10 [0.76-1.58],0.6149890696549352
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,27283,80,2.07 [1.44-2.97],8.606883664614187e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,28102,73,0.60 [0.34-1.07],0.0820407296267051
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26385,176,1.32 [0.97-1.80],0.0804837272216979
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28430,401,1.10 [0.88-1.36],0.4003928280212475
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11674,108,1.34 [0.91-1.99],0.1408372812527499
